未登录 Severe maternal morbidity contributed by obstetric hemorrhage: Maryland, 2020-2022 产科出血导致严重的孕产妇发病率: 马里兰州,2020-2022 Wolfson, Carrie; Angelson, Jessica Tsipe; Atlas, Robert; Burd, Irina; Chin, Pamela; Downey, Cathy; Fahey, Jenifer; Hoffman, Susan; Johnson, Clark T.; Jones, Monica B.; Jones-Beatty, Kimberly; Kasirsky, Jennifer; Kirsch, Daniel; Madan, Ichchha; Neale, Donna; Olaku, Joanne; Phillips, Michelle; Richter, Amber; Sheffield, Jeanne; Silldorff, Danielle; Silverman, David; Starr, Hannah; Vandyck, Rhoda; Creanga, Andreea 分享 收藏
Two-Year Results from the Phase 3 Neovascular Age- Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2 Faricimab治疗和延长给药2年的3期新生血管性年龄相关性黄斑变性试验的两年结果 Khanani, Arshad M.; Kotecha, Aachal; Chang, Andrew; Chen, Shih-Jen; Chen, Youxin; Guymer, Robyn; Heier, Jeffrey S.; Holz, Frank G.; Iida, Tomohiro; Ives, Jane A.; Lim, Jennifer I.; Lin, Hugh; Michels, Stephan; Ruiz, Carlos Quezada; Schmidt-Erfurth, Ursula; Silverman, David; Singh, Rishi; Swaminathan, Balakumar; Willis, Jeffrey R.; Tadayoni, Ramin 分享 收藏
Faricimab Treat-and-Extend for Diabetic Macular Edema Wong, Tien Y.; Haskova, Zdenka; Asik, Kemal; Baumal, Caroline R.; Csaky, Karl G.; Eter, Nicole; Ives, Jane A.; Jaffe, Glenn J.; Korobelnik, Jean-Francois; Lin, Hugh; Murata, Toshinori; Ruamviboonsuk, Paisan; Schlottmann, Patricio G.; Seres, Andras I.; Silverman, David; Sun, Xiaodong; Tang, Yannan; Wells, John A.; Yoon, Young Hee; Wykoff, Charles C. 分享 收藏
Efficacy, Durability, and Safety of Faricimab in Patients From Asian Countries With Diabetic Macular Edema: 1-Year Subgroup Analysis of the Phase III YOSEMITE and RHINE Trials Ishida, Susumu; Chen, Shih-Jen; Murata, Toshinori; Ogura, Yuichiro; Ruamviboonsuk, Paisan; Sakamoto, Taiji; Fujita, Tachie; Kawano, Mika; Ohsawa, Shino; Abreu, Francis; Haskova, Zdenka; Ives, Jane; Silverman, David; Yoon, Young Hee; YOSEMITE RHINE Investigators 分享 收藏
YOSEMITE and RHINE Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale Eter, Nicole; Singh, Rishi P.; Abreu, Francis; Asik, Kemal; Basu, Karen; Baumal, Caroline; Chang, Andrew; Csaky, Karl G.; Haskova, Zdenka; Lin, Hugh; Ruiz, Carlos Quezada; Ruamviboonsuk, Paisan; Silverman, David; Wykoff, Charles C.; Willis, Jeffrey R. 分享 收藏
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials 玻璃体内注射faricimab每16周治疗新生血管性年龄相关性黄斑变性 (TENAYA和LUCERNE) 的疗效、持久性和安全性: 两项随机、双盲、3期非劣效性试验 Heier, Jeffrey S.; Khanani, Arshad M.; Ruiz, Carlos Quezada; Basu, Karen; Ferrone, Philip J.; Brittain, Christopher; Figueroa, Marta S.; Lin, Hugh; Holz, Frank G.; Patel, Vaibhavi; Lai, Timothy Y. Y.; Silverman, David; Regillo, Carl; Swaminathan, Balakumar; Viola, Francesco; Cheung, Chui Ming Gemmy; Wong, Tien Y. 分享 收藏
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials Wykoff, Charles C.; Abreu, Francis; Adamis, Anthony P.; Basu, Karen; Eichenbaum, David A.; Haskova, Zdenka; Lin, Hugh; Loewenstein, Anat; Mohan, Shaun; Pearce, Ian A.; Sakamoto, Taiji; Schlottmann, Patricio G.; Silverman, David; Sun, Jennifer K.; Wells, John A.; Willis, Jeffrey R.; Tadayoni, Ramin 分享 收藏
Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration Khanani, Arshad M.; Guymer, Robyn H.; Basu, Karen; Boston, Heather; Heier, Jeffrey S.; Korobelnik, Jean-Francois; Kotecha, Aachal; Lin, Hugh; Silverman, David; Swaminathan, Balakumar; Willis, Jeffrey R.; Yoon, Young Hee; Quezada-Ruiz, Carlos 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
An institution-wide handoff task force to standardise and improve physician handoffs Horwitz, Leora I.; Schuster, Kevin M.; Thung, Stephen F.; Hersh, David C.; Fisher, Rosemarie L.; Shah, Nidhi; Cushing, William; Nunes, Judy; Silverman, David G.; Jenq, Grace Y. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏